Ex parte TERSTAPPEN et al. - Page 2






                     1.  A method for the multi-parameter analysis of cells in a body fluid wherein said                
              method comprises the steps of:                                                                            
                     1) taking a fluid sample from an individual;                                                       
                     2) adding to said sample a nucleic acid dye;                                                       
                     3) adding to said sample a first fluorescently labelled monoclonal antibody and a                  
              second fluorescently labelled monoclonal antibody, wherein said first antibody recognizes                 
              an antigen that is differentially expressed on said cells and wherein said second antibody                
              recognizes an antigen that is differentially expressed on erythrocyte precursors and                      
              proliferating cells, and further wherein the fluorescent labels on said antibodies have peak              
              emission spectra different from each other and from said nucleic acid dye;                                
                     4) analyzing said cells in an instrument capable of detecting and recording at least               
              three channels of fluorescence and at least two channels of light scatter for each of the                 
              cells in said sample, wherein erythrocytes, mature reticulocytes, immature reticulocytes,                 
              mature nucleated erythrocytes, immature nucleated erythrocytes, progenitors,                              
              megakaryocytes, neutrophils, eosinophils, basophils, monocytes, lymphtocytes, stromal                     
              and epithelial cells are identified, characterized, and enumerated.                                       
                     5.  The method of claim 1 wherein the first monoclonal antibody is an anti-CD45                    
              monoclonal antibody.                                                                                      
                     6.  The method of claim 1 wherein the second monoclonal antibody is an anti-CD71                   
              monoclonal antibody.                                                                                      
                     8.  The method of claim 1 wherein a third fluorescently labelled monoclonal antibody               
              is added wherein said antibody recognizes antigens differentially expressed on platelets.                 





                     The references relied on by the examiner are:                                                      
              Loken et al. (Loken)               5,047,321                   Sep. 10, 1991                              
              Basch et al. (Basch), “Expression of CD4 by human megakaryocytes,” Proc. Natl. Acad.                      
              Sci., USA, Vol. 87, pp. 8085-089 (Oct. 1990)                                                              

                                                           2                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007